CENTER VALLEY, Pa., Nov. 30, 2015 /satPRnews.com/ — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures.
For gastroenterologists, EZDilate provides efficient navigation through difficult anatomy, easier placement and positioning within the stricture, and an accurate achievement of target diameters. Where some balloons have been reported to demonstrate inaccuracy in meeting target diameters, EZDilate research data supports that it more accurately achieves target inflation diameters with no over-inflation required.
According to Truven Health Analytics, approximately 492,000 balloon dilations are conducted each year in the United States. Eighty-eight percent of these procedures are esophageal dilations,[i] conducted to address strictures such as those in the esophagus caused by chronic acid reflux.
The EZDilate balloon dilator is an important addition to the Olympus EndoTherapy line-up because it allows for completion of the full portfolio of core device offerings for gastroenterologists. EZDilate will be available through the ASC Select Program, which is designed to help ambulatory surgery centers obtain high-quality products at reduced prices. Among other products packaged in the ASC Select Program are biopsy forceps, hemostasis clips, polyp traps, biopsy valves and more.
EZDilate balloon dilator provides the following benefits to gastroenterologists:
“I am excited about the release of the Olympus EZ Dilate balloons,” said Dr. Paul Akerman.* “The introduction of the balloons will help complete the Olympus EndoTherapy devices selection. The new balloon has the advantages of improved visualization through the inflated balloon along with the mid balloon endoscopic marker that will assist in accurately placing the balloon. I look forward to using the balloon in clinical practice.”
“This new device is exciting for its advancements in balloon dilation precision and also because of the opportunities it presents our customers for accessing a more complete and cost-effective line-up of EndoTherapy devices from Olympus,” said Richard Reynolds, Executive Vice President – Sales, Marketing of the Medical Systems Group at Olympus Corporation of the Americas. “The announcement builds upon our continuing commitment to the triple aim of healthcare reform – increased quality of care, reduced costs and improved patient satisfaction.”
Designed with performance and patient safety in mind, Olympus’ products help physicians deliver value to patients and help healthcare facilities meet the following key healthcare reform initiatives:
The EZDilate balloon dilator will be showcased at the New York Society of Gastrointestinal Endoscopy (NYSGE) to be held at the New York Marriott Marquis Hotel in Manhattan on December 17-18. Healthcare Providers are invited to visit Olympus at this event for a product demonstration. For more information about EZDilate, please contact Olympus customer service at 1-800-848-9024.
About Olympus Medical Systems Group
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.
For more information visit Olympus at medical.olympusamerica.com.
i Data is Copyright © 2013 of Truven Health Analytics. All Rights Reserved.
ii wire-guided version only
* Dr. Paul Akerman is a contracted physician with Olympus.
Source: PrNewsWire All
Olympus Launches its EZDilate™ Multi-Stage Endoscopic Balloon Dilator